NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Levi Korsinsky notifies investors that it has commenced an investigation of Aldeyra Therapeutics, Inc. ("Aldeyra Therapeutics, Inc.") (NASDAQ:ADLX) concerning possible violations of federal securities laws.On April 3, 2025, The company disclosed that the FDA issued a second Complete…Read More

You might also be interested in reading ELV DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class….